Molecular marker for tumordiagnosis and – therapy
Metastasis is the most critical factor responsible for the failure of cancer treatment. Although protein expression profiling, gene array analysis and determination of critical risk factors in tumor tissue have improved the diagnostic classification of tumors, it is still difficult to predict the risk of metastasis by analyzing the resected primary tumor.
A prominent example is the endometrial cancer, which is the seventh most common malignant disorder in females. It affects 142,000 women worldwide, whereas 42,000 die from this cancer. The complete tumor resection survival usually depends on occurence of metastasis. The manifestation of the metastasis can affect different viscera and bones.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Innovative 3D printed scaffolds offer new hope for bone healing
Researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed PLA-CaP scaffolds that promote blood vessel formation, ensuring better healing and regeneration of bone tissue. Bone is…
The surprising role of gut infection in Alzheimer’s disease
ASU- and Banner Alzheimer’s Institute-led study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral…
Molecular gardening: New enzymes discovered for protein modification pruning
How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…